Compare ETFs: IBB vs. LON:HEAL
IBB
LON:HEAL
Comparison
Average Return
In the past year, IBB returned a total of 36.19%, which is slightly higher than LON:HEAL's 34.99% return. Over the past 10 years, IBB has had annualized average returns of 8.68%, compared to 9.38% for LON:HEAL. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 8.79% |
| 2 | AMGN | Amgen Inc. | 8.22% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.69% |
| 4 | MRNA | Moderna, Inc. | 6.61% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 6.13% |
| 6 | ARGX | argenx SE | 3.59% |
| 7 | NTRA | Natera, Inc. | 2.90% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.59% |
| 9 | BIIB | Biogen Inc. | 2.51% |
| 10 | ONC | BeOne Medicines AG | 2.36% |
| 11 | ILMN | Illumina, Inc. | 2.24% |
| 12 | GMAB | Genmab A/S | 2.08% |
| 13 | INSM | Insmed Incorporated | 1.68% |
| 14 | INCY | Incyte Corporation | 1.65% |
| 15 | UTHR | United Therapeutics Corporation | 1.62% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.43% |
| 17 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.40% |
| 18 | EXEL | Exelixis, Inc. | 1.16% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.14% |
| 20 | CRL | Charles River Laboratories International, Inc. | 1.12% |
| 21 | ASND | Ascendis Pharma A/S | 1.08% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.02% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.92% |
| 24 | HALO | Halozyme Therapeutics, Inc. | 0.78% |
| 25 | TECH | Bio-Techne Corporation | 0.76% |
| View IBB holdings | |||
| LON:HEAL - iShares Healthcare Innovation UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | MRNA | Moderna, Inc. | 6.25% |
| 2 | CPH: GMAB | Genmab A/S | 2.48% |
| 3 | IQV | IQVIA Holdings Inc. | 1.71% |
| 4 | RVTY | Revvity, Inc. | 1.69% |
| 5 | NTRA | Natera, Inc. | 1.64% |
| 6 | KRX: 068270 | Celltrion, Inc. | 1.63% |
| 7 | CRL | Charles River Laboratories International, Inc. | 1.59% |
| 8 | ROIV | Roivant Sciences Ltd. | 1.57% |
| 9 | AMGN | Amgen Inc. | 1.57% |
| 10 | ILMN | Illumina, Inc. | 1.56% |
| 11 | GILD | Gilead Sciences, Inc. | 1.56% |
| 12 | EXEL | Exelixis, Inc. | 1.54% |
| 13 | SWX: LONN | Lonza Group AG | 1.53% |
| 14 | MEDP | Medpace Holdings, Inc. | 1.52% |
| 15 | ABBV | AbbVie Inc. | 1.52% |
| 16 | A | Agilent Technologies, Inc. | 1.51% |
| 17 | BIIB | Biogen Inc. | 1.46% |
| 18 | MDT | Medtronic plc | 1.46% |
| 19 | MRK | Merck & Co., Inc. | 1.44% |
| 20 | DHR | Danaher Corporation | 1.43% |
| 21 | ABT | Abbott Laboratories | 1.41% |
| 22 | JNJ | Johnson & Johnson | 1.37% |
| 23 | EW | Edwards Lifesciences Corporation | 1.36% |
| 24 | GH | Guardant Health, Inc. | 1.36% |
| 25 | PFE | Pfizer Inc. | 1.34% |
| View LON:HEAL holdings | |||